A detailed history of Hsbc Holdings PLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 758,405 shares of TEVA stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
758,405
Previous 1,490,456 49.12%
Holding current value
$13.3 Million
Previous $21 Million 41.4%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.78 - $17.4 $9.36 Million - $12.7 Million
-732,051 Reduced 49.12%
758,405 $12.3 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $1.14 Million - $1.54 Million
-106,722 Reduced 6.68%
1,490,456 $21 Million
Q4 2023

Feb 12, 2024

BUY
$8.12 - $10.63 $9.18 Million - $12 Million
1,130,969 Added 242.59%
1,597,178 $16.7 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $1.16 Million - $1.66 Million
155,388 Added 49.99%
466,209 $4.76 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $30,506 - $40,124
4,237 Added 1.38%
310,821 $2.34 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $977,409 - $1.33 Million
116,915 Added 61.64%
306,584 $2.71 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $554,464 - $661,173
-69,744 Reduced 26.89%
189,669 $1.73 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $1.07 Million - $1.87 Million
-156,666 Reduced 37.65%
259,413 $2.1 Million
Q2 2022

Aug 11, 2022

BUY
$7.38 - $10.4 $555,795 - $783,234
75,311 Added 22.1%
416,079 $3.16 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $363,927 - $466,204
-49,649 Reduced 12.72%
340,768 $3.22 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $232,204 - $299,514
29,393 Added 8.14%
390,417 $3.13 Million
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $140,457 - $170,626
16,761 Added 4.87%
361,024 $3.52 Million
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $397,118 - $463,706
-40,113 Reduced 10.44%
344,263 $3.41 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $389,642 - $482,719
37,683 Added 10.87%
384,376 $4.44 Million
Q4 2020

Feb 25, 2021

SELL
$8.61 - $11.04 $495,074 - $634,800
-57,500 Reduced 14.23%
346,693 $3.35 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $1.21 Million - $1.56 Million
141,024 Added 53.59%
404,193 $3.9 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $601,648 - $890,888
70,204 Added 36.38%
263,169 $2.38 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $3.38 Million - $5.47 Million
-416,825 Reduced 68.36%
192,965 $2.38 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $8.48 Million - $17 Million
-1,266,994 Reduced 67.51%
609,790 $5.53 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $1.32 Million - $2.17 Million
202,086 Added 12.07%
1,876,784 $18.5 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $2.67 Million - $4.16 Million
433,491 Added 34.92%
1,674,698 $11.5 Million
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $615,520 - $1.19 Million
-75,803 Reduced 5.76%
1,241,207 $11.5 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $7.08 Million - $9.09 Million
454,512 Added 52.7%
1,317,010 $20.7 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $2.31 Million - $3.78 Million
158,664 Added 22.54%
862,498 $13.3 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $2.16 Million - $2.63 Million
102,394 Added 17.02%
703,834 $15.2 Million
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $853,609 - $1.26 Million
50,901 Added 9.25%
601,440 $14.6 Million
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $6.62 Million - $8.76 Million
-396,968 Reduced 41.9%
550,539 $9.41 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $5.91 Million - $10.1 Million
-526,583 Reduced 35.72%
947,507 $18 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $15.3 Million - $32 Million
993,494 Added 206.72%
1,474,090 $25.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
480,596
480,596 $16 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.